TXG - 10x Genomics, Inc. -  [ ]

Ticker Details
10x Genomics, Inc.
IPO Date: September 12, 2019
Sector: Healthcare
Industry: Health Information Services
Market Cap: $8.48B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.82 | 3.09%
Avg Daily Range (30 D): $2.06 | 4.24%
Avg Daily Range (90 D): $1.45 | 4.11%
Institutional Daily Volume
Avg Daily Volume: 1.31M
Avg Daily Volume (30 D): 2.6M
Avg Daily Volume (90 D): 2.55M
Trade Size
Avg Trade Size (Sh.): 65
Avg Trade Size (Sh.) (30 D): 66
Avg Trade Size (Sh.) (90 D): 62
Institutional Trades
Total Institutional Trades: 5,371
Avg Institutional Trade: $3.85M
Avg Institutional Trade (30 D): $4.03M
Avg Institutional Trade (90 D): $4.24M
Avg Institutional Trade Volume: .09M
Avg Institutional Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $7.41M
Avg Closing Trade (30 D): $20.46M
Avg Closing Trade (90 D): $16.15M
Avg Closing Volume: 182.62K
 
News
Aug 7, 2026 @ 9:56 AM
Precision Medicine Collaboration and Licensing Dea...
Source: Researchandmarkets.Com
Jul 17, 2026 @ 9:54 AM
Bioinformatics Collaboration and Licensing Deals 2...
Source: Researchandmarkets.Com
Jun 30, 2026 @ 11:58 AM
Spatial Genomics and Transcriptomics Market Size t...
Source: Sns Insider
May 12, 2026 @ 4:39 PM
This $4 Million Bet Shows Growing Confidence in 10...
Source: Jonathan Ponciano
Apr 10, 2026 @ 9:45 AM
Global Next-Generation Sequencing (NGS) Market to ...
Source: Researchandmarkets.Com
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-.59 $-.14 $-.1
Diluted EPS $-.59 $-.14 $-.1
Revenue $616.91M $151.04M $150.84M
Gross Profit $432.03M $112.5M $106.18M
Net Income / Loss $-75.13M $-17.93M $-13.47M
Operating Income / Loss $-88.38M $-19.56M $-17.05M
Cost of Revenue $184.88M $38.54M $44.67M
Net Cash Flow $104.8M $12.23M $16.32M
PE Ratio